A new microscope is capable of live imaging of biological processes in such detail that moving protein complexes are visible.

This industry symposium took place during the European Society for Medical Oncology (ESMO ... and is the practice owner/managing director of Molecular Pathology Baden-Wurttembert, Practice of ...

The following abstracts showcase the top cutting-edge research presented at the European Society for Medical Oncology (ESMO) Congress 2024. Topics covered include the use of AI in breast cancer ...

The market value of the European cement industry was estimated to be over 19.02 billion U.S. dollars in 2023, and it is projected to reach 31 billion U.S. dollars by 2033. Cement is primarily used ...

The structures of the chemicals involved are extremely important to the reactions that take place. Today, modern technology called imaging uses things like sound waves, many types of light, and even ...

Results were presented at the 2023 European Society for Medical Oncology (ESMO) Congress and published in the New England Journal of Medicine. The approval follows the December 2023 and August ...

An updated analysis from the NATALEE trial recently presented at the European Society for Medical Oncology (ESMO) Congress 2024 adds to the growing body of evidence supporting the potential of Kisqali ...

KI researcher Arvid Guterstam at the Division of pshychology receives the SSMF Starting Grant 2025 for the project "Artificial sensory modality for tactile perception others’ attention: A novel ...

Donald Trump said Apple CEO Tim Cook called him to discuss the billions of dollars that Apple has been fined in the European Union. Trump made the statement during his appearance on the PBD ...

The work represents an advancement in hyperpolarized MRI technology, thanks in large part to the collaborative efforts of IBEC's Molecular Imaging for Precision Medicine group and ICFO's Atomic ...

Citation: Palliative and hospice care: Why society cannot ignore the needs of terminally ill patients, and their loved ones (2024, October 16) retrieved 9 November 2024 from https://medicalxpress ...

fell by 17% in September after the company's ESMO (European Society for Medical Oncology) update. 3-year performance isn't looking much better at -81%, as the market clearly thinks very little of ...